(Q37843841)

24 August 2017

1 reference

title

Dendritic cells in hepatitis C infection: can they (help) win the battle? (English)

1 reference

24 August 2017

1 reference

1 reference

Angela Dolganiuc

1

1 reference

24 August 2017

Gyongyi Szabo

series ordinal

2

1 reference

24 August 2017

language of work or name

1 reference

17 February 2011

1 reference

Journal of Gastroenterology

24 August 2017

published in

1 reference

24 August 2017

volume

46

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

432-447

1 reference

Hepatitis C virus infection

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Acute hepatitis C: current status and remaining challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Immunobiology and pathogenesis of viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Immunological determinants of the outcomes from primary hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Peginterferon and ribavirin for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

A step forward in therapy for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Treatment failure in hepatitis C: mechanisms of non-response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Replication of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Expression of the alternative reading frame protein of Hepatitis C virus induces cytokines involved in hepatic injuries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

HCV replication in mononuclear cells stimulates anti‐HCV‐secreting B cells and reflects nonresponsiveness to interferon‐α

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

The divergence and interplay between pDC and mDC in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Inhibitory effects of rat bone marrow-derived dendritic cells on naïve and alloantigen-specific CD4+ T cells: a comparison between dendritic cells generated with GM-CSF plus IL-4 and dendritic cells generated with GM-CSF plus IL-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Hepatitis C infection and alcohol use: A dangerous mix for the liver and antiviral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Flow cytometry assay of myeloid dendritic cells (mDCs) in peripheral blood during acute hepatitis C: possible pathogenetic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Hepatitis C and Innate Immunity: Recent Advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Preserved MHC-II antigen processing and presentation function in chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Viral and Host Factors Induce Macrophage Activation and Loss of Toll-Like Receptor Tolerance in Chronic HCV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Increased PD-L1 expression and PD-L1/CD86 ratio on dendritic cells were associated with impaired dendritic cells function in HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Variant in CD209 promoter is associated with severity of liver disease in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

The tandem-repeat polymorphism of the DC-SIGNR gene in HCV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Early viraemia clearance during antiviral therapy of chronic hepatitis C improves dendritic cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Differential dysfunction in dendritic cell subsets during chronic HCV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Impairment of TLR7-dependent signaling in dendritic cells from chronic hepatitis C virus (HCV)-infected non-responders to interferon/ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Potential role of hepatic progenitor cells expression in cases of chronic hepatitis C and their relation to response to therapy: a clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Involvement of dendritic cell frequency and function in virological relapse in pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Dynamics of immature subsets of dendritic cells during antiviral therapy in HLA-A24-positive chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

A class C CpG toll-like receptor 9 agonist successfully induces robust interferon-alpha production by plasmacytoid dendritic cells from patients chronically infected with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Hepatitis C Virus Is a Weak Inducer of Interferon Alpha in Plasmacytoid Dendritic Cells in Comparison with Influenza and Human Herpesvirus Type-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Differential Effects of Hepatitis C Virus JFH1 on Human Myeloid and Plasmacytoid Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

HCV in peripheral blood mononuclear cells are predominantly carried on the surface of cells in HIV/HCV co-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Dendritic cell susceptibility to hepatitis C virus genotype 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

The origin of hepatitis C virus reinfecting transplanted livers: serum-derived versus peripheral blood mononuclear cell-derived virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Pseudotype hepatitis C virus enters immature myeloid dendritic cells through the interaction with lectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Release and intercellular transfer of cell surface CD81 via microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

C-type lectin DC-SIGN: an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Low stimulatory capacity of lymphoid dendritic cells expressing hepatitis C virus genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

A perspective on modelling hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Hepatitis C virus core, NS3, NS5A, NS5B proteins induce apoptosis in mature dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Monocytes transduced with lentiviral vectors expressing hepatitis C virus non-structural proteins and differentiated into dendritic cells stimulate multi-antigenic CD8(+) T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Hepatitis C virus modulates human monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Diagnosis of occult hepatitis C without the need for a liver biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Host cell responses induced by hepatitis C virus binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Claudin association with CD81 defines hepatitis C virus entry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Toll-like receptor 2 senses hepatitis C virus core protein but not infectious viral particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Immunomodulation by hepatitis C virus-derived proteins: targeting human dendritic cells by multiple mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Generation of cellular immune responses to HCV NS5 protein through in vivo activation of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Functional changes, increased apoptosis, and diminished nuclear factor-kappaB activity of myeloid dendritic cells during chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Functionality of the immune system in patients with chronic hepatitis C: trial by superinfections and vaccinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Hepatitis C virus infection: in vivo and in vitro models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Adoptive transfer of splenocytes to study cell-mediated immune responses in hepatitis C infection using HCV transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Major histocompatibility complex class-I presentation impaired in transgenic mice expressing hepatitis C virus structural proteins during dendritic cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Hepatitis C Virus Proteins Induce Lipogenesis and Defective Triglyceride Secretion in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

The hepatitis C virus non-structural NS5A protein impairs both the innate and adaptive hepatic immune response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Natural killer cells target HCV core proteins during the innate immune response in HCV transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Inhibition of Intrahepatic Gamma Interferon Production by Hepatitis C Virus Nonstructural Protein 5A in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Cell Surface Expression of Major Histocompatibility Complex Class I Molecules Is Reduced in Hepatitis C Virus Subgenomic Replicon-Expressing Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Expression of hepatitis C virus proteins does not interfere with major histocompatibility complex class I processing and presentation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Upregulation of Major Histocompatibility Complex Class I on Liver Cells by Hepatitis C Virus Core Protein via p53 and TAP1 Impairs Natural Killer Cell Cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Host-Specific Response to HCV Infection in the Chimeric SCID-beige/Alb-uPA Mouse Model: Role of the Innate Antiviral Immune Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

High diversity of the immune repertoire in humanized NOD.SCID.gamma c-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Non-human primate surrogate model of hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Infectivity and vaccination efficacy studies in animal models of HBV S and pol gene mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Previously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus Strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Parenchymal expression of CD86/B7.2 contributes to hepatitis C virus-related liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Tolerogenic plasmacytoid DC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Immune dysregulation in lichen sclerosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

The role of innate immunity in autoimmune tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Development of hepatitis C virus vaccines: challenges and progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Presentation of HCV antigens to naive CD8+T cells: why the where, when, what and how are important for virus control and infection outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Dendritic cells transfected with cytopathic self-replicating RNA induce crosspriming of CD8+ T cells and antiviral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Generation of hepatitis C virus-specific cytotoxic T lymphocytes from healthy individuals with peptide-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Distinct intracellular trafficking of hepatitis C virus in myeloid and plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Peptide vaccines for patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Tumor Antigen Presentation by Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Combination strategies for enhancing the efficacy of immunotherapy in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Structural biology of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Altered chemotactic response of myeloid and plasmacytoid dendritic cells from patients with chronic hepatitis C: role of alpha interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Étude du leucotropisme du virus de l’hépatite C par analyse des quasi-espèces virales dans le contexte de la transplantation hépatique

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0377-Y

Immune complex-mediated cytokine production is regulated by classical complement activation both in vivo and in vitro

21 January 2018

1 reference

12 December 2020

Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment

1 reference

12 December 2020

Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C

1 reference

12 December 2020

Human dendritic cells expressing hepatitis C virus core protein display transcriptional and functional changes consistent with maturation

1 reference

12 December 2020

Cutting edge: TLR ligands are not sufficient to break cross-tolerance to self-antigens

1 reference

12 December 2020

CD34+CD38dim cells in the human thymus can differentiate into T, natural killer, and dendritic cells but are distinct from pluripotent stem cells

1 reference

12 December 2020

The influence of interleukin (IL)-4, IL-13, and Flt3 ligand on human dendritic cell differentiation from cord blood CD34+ progenitor cells

1 reference

12 December 2020

Inhibition of dendritic cell maturation by herpes simplex virus

1 reference

12 December 2020

Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion.

1 reference

12 December 2020

Monocyte-derived dendritic cell function in chronic hepatitis C is impaired at physiological numbers of dendritic cells

1 reference

12 December 2020

Adoptive immunotherapy with liver allograft–derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice

1 reference

12 December 2020

FLT3 ligand induces the generation of functionally active dendritic cells in mice

1 reference

12 December 2020

Seropositivity to HCV in Macaca fascicularis.

1 reference

12 December 2020

In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype.

1 reference

12 December 2020

Ordered array of dendritic cells and CD8+ lymphocytes in portal infiltrates in chronic hepatitis C

1 reference

12 December 2020

Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?

1 reference

12 December 2020

Antigen-presenting cells at the liver tissue in patients with chronic viral liver diseases: CD83-positive mature dendritic cells at the vicinity of focal and confluent necrosis

1 reference

12 December 2020

Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells transduced with replication-defective recombinant adenovirus

1 reference

12 December 2020

HCV infection: pathogenesis, clinical manifestations and therapy

1 reference

12 December 2020

10.1007/S00535-011-0377-Y

Identifiers

DOI

1 reference

24 August 2017

1 reference